Gilead Sciences, Inc.
Explore Gilead Sciences
Core profile pages, annual revenue records, and related research hubs for this company.
Gilead Sciences, Inc.
Explore Gilead Sciences
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$29.4B
Market Cap
$161.8B
Net Income
$8.5B
Employees
17,000
Gilead reported $29.44 billion in FY2025 total revenue and $8.51 billion in net income. Total full-year product sales were $28.9 billion, with HIV product sales rising to $20.8 billion and Biktarvy sales reaching $14.3 billion. Liver Disease product sales were $3.2 billion, Cell Therapy product sales were $1.8 billion, Trodelvy sales were $1.4 billion, and Veklury fell to $911 million. R&D expense was $5.8 billion, operating income was $10.02 billion, and the company ended the year with approximately 17,000 employees. The financial story is a mature HIV cash engine funding long-acting HIV prevention, oncology, and cell therapy while management works through patent-cliff and pricing pressure.
Revenue Trend Analysis
YoY Change
+2.4%
3-Year CAGR
+2.3%
Peak Year
2025
Trend
Mostly Growing
Gilead Sciences, Inc. has reported revenue across 4 fiscal years, compounding at +2.3% annually over 3 years. The most recent year saw a 2.4% increase versus the prior year. Revenue peaked in 2025 at $29.4B. Out of 3 reported periods, 2 showed growth and 1 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $29.4B | $8.5B | +2.4% |
| FY2024 | $28.8B | — | +6.0% |
| FY2023 | $27.1B | — | -1.4% |
| FY2022 | $27.5B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Gilead reported about $29.4B in FY2025 revenue.
Profitability depends on product mix, investment levels, pricing, and market conditions; the financials page adds year-by-year context.
Gilead has about 17,000 employees.
The Gilead financials page lists annual revenue history and context for growth, margins, and business mix.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Gilead Sciences, Inc. Revenue & Financials." CorpDigest, https://corpdigest.com/company/gilead-sciences/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Gilead Sciences, Inc. reported $29B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/gilead-sciences/financials" target="_blank" rel="noopener">CorpDigest — Gilead Sciences, Inc. financials</a></div>